The study reported by Jean-Marc Boucher and colleagues in this issue (page 1285)1 provides a thought-provoking, sometimes surprising overview of Canadian care for patients with acute myocardial ...

Sept. 6, 2004 (Stockholm) -- Patients who are scheduled for percutaneous coronary interventions (PCIs) should not be administered thrombolytics beforehand, Belgian researchers report. Preliminary ...

Washington, DC - Thrombolytic therapy can safely reduce the impact of ischemic stroke developing after cardiac catheterization procedures, conclude researchers, who say their retrospective analysis is ...

IRVINE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from ...

Thrombolytic drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. A new study (“Risk of Aneurysm ...

For patients with acute ischemic stroke due to a large-vessel occlusion (LVO), administering intra-arterial thrombolytics after successful endovascular thrombectomy does not significantly improve ...

Revascularization of ischemic tissue and rescue of a still-viable penumbra are valid therapeutic goals, but the literature in support of thrombolytics in acute ischemic stroke should not be ...

TGD001 is being developed to offer patients with clotting disorders a faster, safer and more effective treatment than today’s standard of care – saving lives and reducing disability Following the ...